New China Life Insurance Company Ltd
SSE:601336
New China Life Insurance Company Ltd
Interest Income Expense
New China Life Insurance Company Ltd
Interest Income Expense Peer Comparison
Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors
Company | Interest Income Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
New China Life Insurance Company Ltd
SSE:601336
|
Interest Income Expense
-¥2.1B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
China Life Insurance Co Ltd
SSE:601628
|
Interest Income Expense
-¥20.4B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ping An Insurance Group Co of China Ltd
SSE:601318
|
Interest Income Expense
-¥23.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-26%
|
|
H
|
Hubei Biocause Pharmaceutical Co Ltd
SZSE:000627
|
Interest Income Expense
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
S
|
Sunshine Insurance Group Co Ltd
HKEX:6963
|
Interest Income Expense
-¥1.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is New China Life Insurance Company Ltd's Interest Income Expense?
Interest Income Expense
-2.1B
CNY
Based on the financial report for Dec 31, 2023, New China Life Insurance Company Ltd's Interest Income Expense amounts to -2.1B CNY.
What is New China Life Insurance Company Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
-14%
Over the last year, the Interest Income Expense growth was -78%. The average annual Interest Income Expense growth rates for New China Life Insurance Company Ltd have been -17% over the past three years , -14% over the past five years .